DRUG GUIDELINE

Ocrelizumab Intravenous Infusion

SCOPE (Area): Pharmacy., Medical Day Unit

SCOPE (Staff): Medical, Nursing, Clinical Staff, Pharmacy, Nurse Unit Managers, Clinical Teachers/staff Educators

Printed versions of this document SHOULD NOT be considered up to date / current

Paediatrics (seek Paediatrician advice), and other areas

	Alfred Healthâ€™s Drug Guideline for â€œOcrelizumab in multiple sclerosis â€“ administration and monitoringâ€?, 9th Aug 2017.
	Barwon Healthâ€™s Drug Guidelines â€œOcrelizumab (Ocrevus) for multiple sclerosis admin and monitoringâ€?, 9th Nov 2017.
	Eastern Health Practice Guidelines for â€œPrescribing and administration of Ocrelizumab (Ocrevus) in adults with Relapsing Remitting and Primary Progressive Multiple Sclerosisâ€?, 20th Apr 2017.
	Rossi, S. (2018). Australian Medicines Handbook. Retrieved 18th Apr 2018, from https://amhonline.amh.net.au.acs.hcn.com.au/?acc=36265.
	The Society of Hospital Pharmacists of Australia. 2017. Australian Injectable Drugs Handbook (7th ed.). Retrieved 18th Apr 2018, from http://aidh.hcn.com.au/browse/about_aidh.
	Thomson Reuters. (2017). Micromedex Solutions. Retrieved Apr 18th 2018, from http://www.micromedexsolutions.com.acs.hcn.com.au/micromedex2/librarian?acc=36265.
	UBM Medica. (2017, July). MIMS Online, Ocrelizumab. Retrieved Apr 18th 2018, from https://www.mimsonline.com.au.acs.hcn.com.au//Search/Search.aspx?acc=36265.
	UpToDate, Inc. (2017) UpToDate. Retrieved Apr 24th 2018, http://www.uptodate.com/crlsql/interact/frameset.jsp.

Reg Authority: Medication Safety & Governance Committee (MSGC)	Date Effective: 25/11/2020
Review Responsibility: Pharmacist - Rotational	Date for Review: 30/09/2024

Ocrelizumab Intravenous Infusion - DRG0058 - Version: 2 - (Generated On: 21-06-2025 05:48)